Rinath M Jeselsohn

Medical oncologist and clinical investigator at Dana-Farber Cancer Institute specializing in endocrine therapy resistance and novel agents for hormone receptor–positive metastatic breast cancer, contributing expert interpretation of trial data.

Best podcasts with Rinath M Jeselsohn

Ranked by the Snipd community

7 snips

Nov 29, 2025 • 59min

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2

Dr. Rinath M Jeselsohn, a specialist in endocrine therapy resistance at Dana-Farber, and Dr. Joyce O’Shaughnessy, known for her expertise in breast cancer trials, dive into the latest in metastatic breast cancer treatments. They discuss the efficacy of oral selective estrogen receptor degraders, the importance of ctDNA testing for ESR1 mutations, and choices for therapy post-CDK4/6 progression. Insights into combination therapies and recent trial results illuminate the complexities of treatment strategies, providing a comprehensive overview for clinicians.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app